Head-to-head · WeighScore
Fitish vs REMEVi
By GLP-1 ScorecardUpdated
Score comparison
REMEVi has the higher recorded score — 73.5/100 to 60.9/100.
REMEVi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Fitish | REMEVi |
|---|---|---|
| WeighScore | 60.9/100 | 73.5/100 |
| Grade | C | C |
| Site position | #349 | #78 |
| Semaglutide | $219/mo (compounded) | $219/mo |
| Tirzepatide | $339/mo (compounded) | $319/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #349 · C
FDAWarning letter issued to FITISH in June 2026. See the FDA warning-letter database.
Strengths
- LegitScript certified
- Ships to all US states
- Price includes consult, shipping, and medication
- Injectable and oral tablet formats
- Microdosing option available
What to consider
- No physical address disclosed
- Broader wellness/beauty brand — GLP-1 is one product line
- Compounded only — no brand-name options
- FDA issued FITISH a warning letter in June 2026; the letter is public in FDA's warning-letter database
Site position #78 · C
Strengths
- A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
- Longer terms are published openly rather than used as a teaser — semaglutide falls to $189 on 12 weeks and $149 on 52
- A daily oral semaglutide tablet is offered alongside the injection
- Available in all 50 states and DC, with no minimum commitment and no cancellation fee
What to consider
- The flat rate is the highest entry price of the top-scoring programs here; the cheaper $149 figure needs a full year
- No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.